COMMUNIQUÉS West-GlobeNewswire

RavenQuest Signs Services Contract With Alexander First Nation
15/08/2018
VANCOUVER, British Columbia, Aug. 15, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) is pleased to announce it has entered into a services [...]
HealthLynked Corp. Reports Second Quarter 2018 Results, including 10% Revenue Growth in the Second Quarter of 2018
15/08/2018
NAPLES, Fla., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Naples, FL August 15, 2018 – HealthLynked Corp. (OTCQB: HLYK ), late yesterday reported its results for the second quarter of 2018. Second Quarter 2018 Highlights: 10% [...]
Solon Eiendom ASA : Invitation to presentation of second quarter 2018 results
15/08/2018
Oslo, 15 August 2018 - Solon Eiendom ASA will publish its second quarter 2018 results on Wednesday 22 August at 08.00 am CET. The quarterly report and the presentation will be available on the company's web site, www. [...]
Rule 2.9 Announcement
15/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 15 August 2018 [...]
Delivery of study drug to the PledOx® phase III program is expected in September
15/08/2018
Stockholm, August 15, 2018. PledPharma AB (publ) announces today that delivery of PledOx ® study drug for the planned phase III program is expected during September 2018. As previously announced, dosing of first patient [...]
William Demant Holding A/S: Interim Report 2018
15/08/2018
Company announcement no 2018-08 Interim Report 2018 15 August 2018 Hearing aid wholesale delivered strong organic growth of 11% and expands industry-leading product portfolio Growth in local currencies was 9% for the [...]
Six-month interim report (Q2) 2018
15/08/2018
Better than expected performance in Q2 (unaudited) ALK’s financial performance in Q2 was better than expected and full-year outlook has been improved. The execution of ALK’s new growth strategy is on track, with good [...]
Esperite N.V. (ESP) : Update on the publication of the Annual Report 2017.
15/08/2018
Amsterdam, The Netherlands - 15 August 2018 Esperite NV announces having solved the technical issues that caused the delay regarding the publication of the Annual Report 2017. The departments involved are now able to [...]
CrownBio étend sa sélection de modèles génétiquement modifiés grâce à une alliance stratégique avec le Shanghai Model Organisms Center (SMOC)
15/08/2018
Cette alliance permet aux chercheurs d'accéder à des milliers de GEMM SAN DIEGO, 15 août 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, une société mondiale de services de recherche et de développement de médicaments [...]
Scythian Biosciences to Commence Trading on the Canadian Securities Exchange
15/08/2018
TORONTO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Shares of Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl: SCCYF) is pleased to announce that it will commence [...]
Vigil Reports Increased Revenue and Earnings in First Quarter
14/08/2018
VICTORIA, British Columbia, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”) announces the results of operations for the quarter ending June 30, 2018. Business Highlights Revenue of $1.64 million [...]
Milestone Scientific Provides Business Update for the Second Quarter of 2018
14/08/2018
LIVINGSTON, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a [...]
Synergy CHC Corp. Announces Second Quarter 2018 Results
14/08/2018
Westbrook, Maine, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended June 30, 2018 [...]
ContraFect to Participate in FDA Workshop on Development of Non-Traditional Therapies for Bacterial Infections
14/08/2018
YONKERS, N.Y., Aug. 14, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
Organovo Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
14/08/2018
SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo” or the “Company”) announced the grant of inducement awards on August 14, 2018 to Dr. Steven G. Hughes, its new chief medical [...]
VistaGen Therapeutics Reports Fiscal 2019 First Quarter Financial Results
14/08/2018
SOUTH SAN FRANCISCO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other [...]
Atrion Corporation Increases Quarterly Cash Dividend by 13%
14/08/2018
ALLEN, Texas, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq: ATRI) today announced an increase in its quarterly cash dividend from $1.20 per share to $1.35 per share. Specifically, the Board of Directors [...]
Mateon Therapeutics Reports Second Quarter 2018 Financial Results
14/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
14/08/2018
DUBLIN, Ireland and TREVOSE, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP) (the “Company”) today announced that it intends to offer and sell 9,000,000 of its ordinary shares in an [...]

Pages